Genes Predict Mesothelioma Treatment Response – Surviving Mesothelioma
 Surviving Mesothelioma | Genes Predict Mesothelioma Treatment Response Surviving Mesothelioma University of Chicago researchers have released the results of genetic studies they hope will shed some light on why some mesothelioma patients respond well to pemetrexed (Alimta) while others do not. In 2004, pemetrexed was the first medicine approved ... |
Fri, Dec 23, 2011
Alimta News